The ResM GLP-1 Postbiotic is designed to integrate GLP-1 (glucagon-like peptide-1) into its formulation to help modulate critical gut hormones, promoting digestive wellness and improved metabolic balance
Common side effects are usually mild and temporary
It applies to every semaglutide and tirzepatide product on the market
A small change in lean mass on a scan may be less concerning than a patient who reports: New falls or near-falls Progressive weakness Difficulty getting out of a chair Reduced walking tolerance Inability to perform usual daily activities Persistent dizziness or dehydration Severe appetite loss Inability to consume adequate nutrition Loss of training capacity Rapid, unplanned, or poorly tolerated weight loss These are not simply body-composition issues
When coming off a GLP-1, watch for increased hunger and food noise persistent, intrusive thoughts about food as well as a diminished ability to feel full with smaller portions
Because GLP-1 medications suppress appetite, many users eat less
